To underscore this point, Polo-like kinase 1 (PLK1) and the monopolar spindle 1 (Mps1) kinase, two kinases involved in the regulation of the CPC, are therapeutic targets in high-risk neuroblastoma [206,207]. Here, PLK1 is linked to neuroblastoma.